Using two distinct mouse models we subsequently demonstrate that genetic deletion of Tph1 in mast cells reduces WAT serotonin and enhances WAT Ucp1 and whole-body energy expenditure; an effect associated with a reduction in high-fat diet-induced obesity, insulin resistance and NAFLD. The gene discussed is TPH1; the disease is metabolic dysfunction-associated steatotic liver disease.